Tvardi Therapeutics (TVRD) Change in Cash: 2012-2024
Historic Change in Cash for Tvardi Therapeutics (TVRD) over the last 13 years, with Dec 2024 value amounting to -$15.8 million.
- Tvardi Therapeutics' Change in Cash fell 141.75% to -$3.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.4 million, marking a year-over-year decrease of 51.96%. This contributed to the annual value of -$15.8 million for FY2024, which is 50.77% down from last year.
- Per Tvardi Therapeutics' latest filing, its Change in Cash stood at -$15.8 million for FY2024, which was down 50.77% from -$10.5 million recorded in FY2023.
- In the past 5 years, Tvardi Therapeutics' Change in Cash registered a high of $50.3 million during FY2022, and its lowest value of -$18.2 million during FY2021.
- In the last 3 years, Tvardi Therapeutics' Change in Cash had a median value of -$10.5 million in 2023 and averaged $8.0 million.
- As far as peak fluctuations go, Tvardi Therapeutics' Change in Cash crashed by 236.27% in 2021, and later surged by 375.85% in 2022.
- Tvardi Therapeutics' Change in Cash (Yearly) stood at $13.4 million in 2020, then slumped by 236.27% to -$18.2 million in 2021, then soared by 375.85% to $50.3 million in 2022, then plummeted by 120.81% to -$10.5 million in 2023, then plummeted by 50.77% to -$15.8 million in 2024.